Overview of Glp 1 Drugs Causing Nutritionaldeficiencies In New Study Robert

New study shows GLP-1 drugs like Ozempic may cause nutritional deficiencies and muscle loss. Learn the risks and how to protect your health.

A new study suggests that these effects might put users at risk of becoming deficient in some key vitamins and minerals. In the analysis, published in the February 2026 issue of Clinical Obesity, researchers reviewed six studies involving 480,825 adults with diabetes, obesity, or both who were taking GLP-1 drugs .
Study finds nutritional risks in users of GLP

Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional deficiencies ...
A new study published in Frontiers in Nutrition warns that people taking popular GLP-1 weight-loss drugs for obesity such as semaglutide (Ozempic) and tirzepatide (Mounjaro) may not be getting enough essential nutrients, putting their long-term health at risk.

New study
This week, I'm unpacking a brand new study by Butsch et al. (2025) that reveals just how common nutritional deficiencies are with GLP-1 medications and what you can do about it. Let's get into it!
Emerging research suggests that within months of starting these drugs , many people begin to fall short on essential nutrients their bodies need to function properly. For instance, in a Cleveland Clinic study of 460,000 adults prescribed a GLP-1 drug , nearly 1 in 5 developed a nutrient deficiency within a year - many without realising it.

Can GLP
The study observed that nutritional deficiencies were diagnosed in 12.7 percent of patients within six months of starting GLP-1 therapy and 22.4 percent within 12 months.
How GLP-1 Weight Loss Drugs Work Drugs such as semaglutide and tirzepatide, sold under brand names including Ozempic, Wegovy and Mounjaro, work by copying the effects of glucagon like peptide-1 ...

What Nutrients Are GLP
As clinical use of GLP-1 drugs expands, concerns have emerged about associated nutritional and micronutrient deficiencies, particularly in individuals with obesity who are already predisposed due ...




Abstract Background Glucagon-like peptide-1 receptor agonists ( GLP -1RAs) drug -induced weight loss is associated with fat mass reduction but can also lead to nutritional deficiencies and loss of muscle. We quantified nutritional deficiencies in adults who had undergone GLP -1RA treatment.